Ledyard National Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.13M Sell
4,276
-595
-12% -$608K 0.41% 51
2026
Q1
$4.48M Sell
4,871
-60
-1% -$60.8K 0.39% 57
2025
Q4
$5.3M Buy
4,931
+136
+3% +$130K 0.46% 46
2025
Q3
$3.66M Sell
4,795
-88
-2% -$65.5K 0.33% 62
2025
Q2
$3.81M Buy
4,883
+376
+8% +$292K 0.36% 63
2025
Q1
$3.72M Sell
4,507
-18
-0.4% -$15K 0.37% 62
2024
Q4
$3.49M Sell
4,525
-11
-0.2% -$9.11K 0.33% 67
2024
Q3
$4.02M Buy
4,536
+153
+3% +$138K 0.37% 63
2024
Q2
$3.97M Buy
4,383
+485
+12% +$388K 0.39% 59
2024
Q1
$3.03M Sell
3,898
-100
-3% -$71.2K 0.29% 68
2023
Q4
$2.33M Buy
3,998
+22
+0.6% +$12.8K 0.24% 73
2023
Q3
$2.14M Buy
3,976
+20
+0.5% +$10.3K 0.24% 73
2023
Q2
$1.86M Sell
3,956
-210
-5% -$88.1K 0.2% 83
2023
Q1
$1.43M Sell
4,166
-134
-3% -$45.2K 0.16% 94
2022
Q4
$1.57M Buy
4,300
+15
+0.4% +$5.32K 0.19% 92
2022
Q3
$1.39M Buy
4,285
+347
+9% +$110K 0.18% 96
2022
Q2
$1.28M Buy
3,938
+5
+0.1% +$1.5K 0.15% 105
2022
Q1
$1.13M Sell
3,933
-86
-2% -$22.1K 0.11% 115
2021
Q4
$1.11M Buy
4,019
+9
+0.2% +$2.28K 0.11% 122
2021
Q3
$926K Hold
4,010
0.1% 130
2021
Q2
$920K Sell
4,010
-226
-5% -$45.4K 0.09% 128
2021
Q1
$791K Buy
4,236
+113
+3% +$22.1K 0.09% 126
2020
Q4
$696K Hold
4,123
0.08% 131
2020
Q3
$610K Sell
4,123
-425
-9% -$65.8K 0.08% 133
2020
Q2
$747K Sell
4,548
-200
-4% -$30.7K 0.1% 125
2020
Q1
$659K Hold
4,748
0.1% 131
2019
Q4
$624K Hold
4,748
0.08% 153
2019
Q3
$531K Hold
4,748
0.07% 160
2019
Q2
$526K Sell
4,748
-225
-5% -$26.5K 0.07% 164
2019
Q1
$645K Sell
4,973
-271
-5% -$33K 0.09% 160
2018
Q4
$607K Hold
5,244
0.08% 170
2018
Q3
$562K Buy
5,244
+31
+0.6% +$3.1K 0.06% 194
2018
Q2
$445K Hold
5,213
0.05% 205
2018
Q1
$403K Buy
5,213
+800
+18% +$64.4K 0.05% 224
2017
Q4
$373K Buy
4,413
+9
+0.2% +$766 0.05% 233
2017
Q3
$377K Hold
4,404
0.05% 220
2017
Q2
$363K Buy
4,404
+1,150
+35% +$93.8K 0.05% 199
2017
Q1
$274K Buy
3,254
+307
+10% +$24.6K 0.04% 225
2016
Q4
$217K Buy
2,947
+74
+3% +$5.51K 0.04% 190
2016
Q3
$230K Buy
2,873
+566
+25% +$45.3K 0.04% 184
2016
Q2
$181K Sell
2,307
-93
-4% -$7K 0.03% 197
2016
Q1
$173K Hold
2,400
0.03% 197
2015
Q4
$202K Sell
2,400
-14
-0.6% -$1.16K 0.04% 180
2015
Q3
$202K Sell
2,414
-100
-4% -$8.44K 0.04% 174
2015
Q2
$209K Buy
2,514
+664
+36% +$50.6K 0.04% 168
2015
Q1
$134K Hold
1,850
0.02% 203
2014
Q4
$128K Sell
1,850
-75
-4% -$5.06K 0.02% 199
2014
Q3
$125K Hold
1,925
0.02% 193
2014
Q2
$120K Buy
1,925
+75
+4% +$4.47K 0.02% 194
2014
Q1
$109K Sell
1,850
-83
-4% -$4.63K 0.02% 194
2013
Q4
$99K Hold
1,933
0.02% 197
2013
Q3
$97K Hold
1,933
0.02% 186
2013
Q2
$95K Buy
+1,933
New +$105K 0.02% 184

Other funds holding LLY

Ledyard National Bank's LLY Position: Q2 2026 in Review

Ledyard National Bank reduced its Eli Lilly (LLY) stake by 12% in Q2 2026, selling an estimated $608K and leaving 4,276 shares worth $5.13M. The position accounts for 0.41% of the portfolio, ranked #51.

Ledyard National Bank first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.3M in Q4 2025. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ledyard National Bank held 4,276 shares of Eli Lilly worth $5.13M as of Q2 2026.
  • Ledyard National Bank sold 595 Eli Lilly shares in Q2 2026, an estimated $608K.
  • Eli Lilly made up 0.41% of Ledyard National Bank's portfolio in Q2 2026, its #51 holding.
  • Ledyard National Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • Ledyard National Bank's Eli Lilly position peaked at $5.3M in Q4 2025.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ledyard National Bank's 13F filing for Q2 2026, filed 16 Jul 2026.